-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Hepion Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2014 to 2024.
- Hepion Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2025 was -$1.04M, a 73.4% increase year-over-year.
- Hepion Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2025 was -$13.6M, a 52.2% increase year-over-year.
- Hepion Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$13.2M, a 73% increase from 2023.
- Hepion Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$48.9M, a 15.9% decline from 2022.
- Hepion Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$42.2M, a 29% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)